Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Navient Shares Gain Post Q2 Results

Navient Corp (NASDAQ:NAVI) reported second-quarter adjusted core earnings EPS of $0.92, beating the consensus of $0.79. Q2 Net interest income…
byAkanksha Bakshi
July 26, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0
  • Navient Corp (NASDAQ:NAVI) reported second-quarter adjusted core earnings EPS of $0.92, beating the consensus of $0.79.
  • Q2 Net interest income was $321 million (-0.3% year-over-year); and Other Income totaled $134 million (-23.9% Y/Y).
  • Federal education Loan Q2 net income was $110 million, compared to $113 million a year ago. FFELP net interest margin was 1.11% vs. 0.97% a year ago.
  • The Consumer Lending segment’s net income was $71 million, compared to $6 million. Originated $420 million of Private Education Loans compared to $1.3 billion.
  • Business Processing segment revenue totaled $87 million (-33.1% Y/Y), and EBITDA margin declined to 16% from 30% in 2Q21. Net income was $10 million compared to $29 million a year ago.
  • Navient repurchased 6.9 million shares during the quarter for $105 million.
  • The adjusted tangible equity ratio was 7.5%.
  • Price Action: NAVI shares are trading higher by 3% at $15.80 during the post-market session on Tuesday.
 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Dyne Therapeutics Announces Upcoming Presentations On Initial Clinical Data From Its ACHIEVE Trial In DM1 Patients And DELIVER Trial In DMD Patients At The 2024 Muscular Dystrophy Association Clinical & Scientific Conference

By Benzinga Newsdesk
February 14, 6:09 PM
- Presentations will Highlight Initial Data Announced in January 2024 Demonstrating Proof-of-Concept in its DM1 and DMD Programs, Validating the Promise of the FORCE™ Platform and Targeted Delivery to Muscle

DYN